Answers are grounded in this paper and cite their sources.
Background:Nelumbo nucifera (lotus) has been widely used in traditional Chinese medicine for centuries to treat various disorders, including cardiovascular diseases (CVDs), microbial infections, diabetes, and cancer. Liensinine, a natural alkaloid isolated from this plant, exhibits diverse pharmacological activities, including modulation of autophagy, induction of apoptosis in cancer cells, and cardioprotective effects in models of myocardial infarction. Since CVDs are closely associated with platelet activation, which plays a key role in arterial thrombosis, suppressing platelet activation may be a useful strategy for thrombotic diseases; however, the antiplatelet potential of liensinine remains to be fully elucidated. Therefore, this study was designed to evaluate the effects of liensinine on platelet activation in human platelets.Materials and Methods:Platelet aggregometry, a luciferin–luciferase assay, fluorescence analysis, flow cytometry, immunoblotting, confocal microscopy, scanning electron microscopy (SEM), and an in vivo thrombosis model were used in this study.Results:Liensinine inhibited collagen-induced platelet aggregation in a concentration-dependent manner and exerted a moderate inhibitory effect on thrombin-induced aggregation; however, no effects were observed for liensinine on arachidonic acid-induced aggregation. Moreover, liensinine did not increase lactate dehydrogenase release even at concentrations up to 160 μM, indicating an absence of platelet cytotoxicity. Liensinine also reduced collagen-induced Ca2+ mobilization, ATP release, and P-selectin expression. Mechanistically, liensinine attenuated collagen-stimulated phosphorylation of phospholipase C gamma 2 (PLCγ2) and protein kinase C (PKC). In contrast, liensinine did not inhibit platelet aggregation induced by phorbol 12,13-dibutyrate (PDBu), a direct PKC activator. Furthermore, SEM analysis showed that liensinine reduced collagen-induced filopodial elongation in platelets. In the animal experiment, liensinine significantly prolonged the occlusion time of thrombotic platelet plug formation in mesenteric vessels.Conclusion:These findings demonstrate that liensinine inhibits collagen-induced platelet activation by suppressing the PLCγ2–PKC signaling cascade, thereby reducing Ca2+ mobilization and granule secretion and attenuating platelet morphological changes and aggregation. Overall, the present results suggest that liensinine possesses antiplatelet and antithrombotic activity.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: